2m 2m 2m 2m 2m 2m 2m
IMMUNEERING-A (IMRX)
NASDAQ
$4.51-$0.04 (-0.99%)
Price as of Jun 03, 2026 7:58 PM EDT- $373.3MMarket Cap
- 118.37%1-Year Change
- BiotechnologyIndustry
IMMUNEERING-A (IMRX)
$4.51-$0.04 (-0.99%)
IMRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.55 | ||
Change | -$0.21 (-4.78%) | ||
Open | $4.29 | ||
High | $4.60 | ||
Low | $4.23 | ||
Previous Close | $4.28 | ||
Volume | 1,938,479 | ||
30-Day Average Volume | 1,978,259 | ||
1-Week Change | -18.79% | ||
1-Month Change | -20.30% | ||
1-Year Change | 118.37% | ||
3-Year Change | -51.09% | ||
5-Year Change | 8,067.94% | ||
Fundamentals | |||
Shares Outstanding | 64.7M | ||
Total Assets | $214.8M | ||
Market Cap | $373.3M | ||
Enterprise Value | $326.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$13.5M | ||
Free Cash Flow | -$18.5M | ||
EBIT | -$13.5M | ||
EBITDA | -$13.5M | ||
Net Working Capital | N/A | ||
EPS | -$0.21 | ||
Enterprise Value/EBITDA | -24 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -27 | ||
PEG | -1 | ||
Price/Free Cash Flow | -20 | ||
Price/Operating Cash Flow | -20 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue